1. Home
  2. LYRA vs CNET Comparison

LYRA vs CNET Comparison

Compare LYRA & CNET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LYRA
  • CNET
  • Stock Information
  • Founded
  • LYRA 2005
  • CNET 2003
  • Country
  • LYRA United States
  • CNET Hong Kong
  • Employees
  • LYRA N/A
  • CNET N/A
  • Industry
  • LYRA Medical/Dental Instruments
  • CNET Advertising
  • Sector
  • LYRA Health Care
  • CNET Consumer Discretionary
  • Exchange
  • LYRA Nasdaq
  • CNET Nasdaq
  • Market Cap
  • LYRA 7.6M
  • CNET 6.3M
  • IPO Year
  • LYRA 2020
  • CNET N/A
  • Fundamental
  • Price
  • LYRA $3.88
  • CNET $1.93
  • Analyst Decision
  • LYRA Hold
  • CNET
  • Analyst Count
  • LYRA 1
  • CNET 0
  • Target Price
  • LYRA $16.00
  • CNET N/A
  • AVG Volume (30 Days)
  • LYRA 30.6K
  • CNET 5.8K
  • Earning Date
  • LYRA 11-12-2025
  • CNET 11-19-2025
  • Dividend Yield
  • LYRA N/A
  • CNET N/A
  • EPS Growth
  • LYRA N/A
  • CNET N/A
  • EPS
  • LYRA N/A
  • CNET N/A
  • Revenue
  • LYRA $600,000.00
  • CNET $6,166,000.00
  • Revenue This Year
  • LYRA N/A
  • CNET N/A
  • Revenue Next Year
  • LYRA $106.28
  • CNET N/A
  • P/E Ratio
  • LYRA N/A
  • CNET N/A
  • Revenue Growth
  • LYRA N/A
  • CNET N/A
  • 52 Week Low
  • LYRA $3.69
  • CNET $0.96
  • 52 Week High
  • LYRA $37.50
  • CNET $2.78
  • Technical
  • Relative Strength Index (RSI)
  • LYRA 22.62
  • CNET 46.89
  • Support Level
  • LYRA $5.40
  • CNET $1.84
  • Resistance Level
  • LYRA $4.80
  • CNET $2.16
  • Average True Range (ATR)
  • LYRA 0.42
  • CNET 0.09
  • MACD
  • LYRA -0.17
  • CNET -0.01
  • Stochastic Oscillator
  • LYRA 7.39
  • CNET 36.11

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

About CNET ZW Data Action Technologies Inc.

ZW Data Action Technologies Inc is engaged in providing Internet advertising, precision marketing, e-commerce online to offline (O2O) advertising and marketing services as well as related data and technical services to small and medium enterprises in the PRC. It offers a variety channel of advertising and marketing services through its system, including distribution of the right to use search engine marketing services, provision of online advertising placements on its web portals, provision of e-commerce O2O advertising and marketing services, and provision of other related value-added data and technical services to maximize market exposure and effectiveness for clients.

Share on Social Networks: